REGN holders · Bridgewater Associates, LP 13F · REGN stock
Bridgewater Associates, LP Regeneron Pharmaceuticals Inc (REGN) 13F holding
Bridgewater Associates, LP reported 51,333 REGN shares valued at $32.0M as of 2026-06-30. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars. Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-06-30 | 51,333 | $32.0M | COM |
| 2025-09-30 | 235,381 | $132.3M | COM |
| 2025-06-30 | 89,047 | $46.7M | COM |
| 2025-03-31 | 20,991 | $13.3M | COM |
| 2024-12-31 | 289 | $205.9K | COM |
Not investment advice. Cached 13F row, not EDGAR XML.